Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Management: Follow a balanced, diabetes-friendly diet and limit intake of high-sugar foods
The FDA currently approves semaglutide for weight management in adults with a body mass index (BMI) of 30 or greater (classified as obesity), or a BMI of 27 or greater with at least one weight-related health condition, such as hypertension, type 2 diabetes, or high cholesterol
Each pre-filled pen injector contains 60 mg of tirzepatide per 2.4 mL of the solution
Phase 3 clinical trials into survodutide, a new GLP-1, showed it has the potential to combat NASH, one of the complications of NAFLD, with significant improvements seen in 83.0% of patients
US$ 28.23
US$ 25.50
US$ 29.75
US$ 29.22
